Camptocormia as a Novel Phenotype in a Heterozygous <i>POLG2</i> Mutation
Mitochondrial dysfunction is known to play a key role in the pathophysiological pathway of neurodegenerative disorders. Nuclear-encoded proteins are involved in mtDNA replication, including DNA polymerase gamma, which is the only known replicative mtDNA polymerase, encoded by nuclear genes Polymeras...
Main Authors: | Diana Lehmann Urban, Leila Motlagh Scholle, Kerstin Alt, Albert C. Ludolph, Angela Rosenbohm |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/2/68 |
Similar Items
-
A new pathogenic POLG variant
by: S. Nicholas Russo, et al.
Published: (2022-09-01) -
Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
by: Josef Finsterer
Published: (2023-09-01) -
POLG1-Related Epilepsy: Review of Diagnostic and Therapeutic Findings
by: Nicola Specchio, et al.
Published: (2020-10-01) -
Camptocormia as the presenting symptom in sporadic late onset nemaline myopathy: a case report
by: Matthias Türk, et al.
Published: (2019-11-01) -
Potential toxicity of quercetin: The repression of mitochondrial copy number via decreased POLG expression and excessive TFAM expression in irradiated murine bone marrow
by: Ruiqing Chen, et al.
Published: (2014-01-01)